PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsendocarditis
MeSH D004696 - endocarditis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D006331:Heart diseases
0 Companies
0 Drugs
Success rate
D004696: 
Endocarditis
$
Success rate
D004697:Bacterial endocarditis
D059905:Non-infective endocarditis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaGentamicin Gentamicin  1991-11-21   
Penicillin g Penicillin  1982-01-01   
Penicillin g Penicillin G Potassium  1982-01-01   
PadagisGentamicin Gentamicin  1982-01-01   
Taro PharmaceuticalGentamicin Gentamicin  1983-05-26   
SandozGentamicin Gentamicin  1982-01-01   
Penicillin g Penicillin G  2001-02-26   
Penicillin g Penicillin G Potassium  2002-08-30   
NovartisGentamicin Gentacidin  1984-03-30   
WyethPenicillin g benzathine Bicillin  1982-01-01   
Penicillin g benzathine Bicillin L-a  1982-01-01   
Gentamicin Gentamicin  1982-01-01   
Penicillin g Penicillin G Potassium  1982-01-01   
King PharmaceuticalsGentamicin Apogen  1982-01-01   
Penicillin g benzathine, Penicillin g procaine Bicillin C-r  1982-01-01   
Penicillin g benzathine Bicillin L-a  1982-01-01   
Penicillin g procaine Penicillin G Procaine  1982-01-01   
AlpharmaGentamicin Gentamicin  1983-09-27   
Bausch Health CompaniesGentamicin Gentamicin  1994-05-11   
Merck & CoGentamicin Garamycin  1982-01-01   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
56%
5/9
Phase 3
71%
15/21
Approved: 4Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Allergan
Pfizer
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use